IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 117 filers reported holding IMMUNOVANT INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,862,537 | +109.0% | 74,565 | +3.3% | 0.00% | +50.0% |
| Q2 2023 | $1,369,596 | +123176.0% | 72,198 | +0.8% | 0.00% | +100.0% |
| Q1 2023 | $1,111 | -10.4% | 71,648 | +2.6% | 0.00% | -50.0% |
| Q4 2022 | $1,240 | -99.6% | 69,842 | +12.0% | 0.00% | +100.0% |
| Q3 2022 | $348,000 | +53.3% | 62,382 | +7.2% | 0.00% | – |
| Q2 2022 | $227,000 | -9.6% | 58,175 | +28.0% | 0.00% | – |
| Q1 2022 | $251,000 | -35.3% | 45,464 | -0.1% | 0.00% | – |
| Q4 2021 | $388,000 | -3.2% | 45,489 | -1.3% | 0.00% | -100.0% |
| Q3 2021 | $401,000 | -14.1% | 46,090 | +4.3% | 0.00% | 0.0% |
| Q2 2021 | $467,000 | -30.6% | 44,210 | +5.4% | 0.00% | 0.0% |
| Q1 2021 | $673,000 | -66.7% | 41,958 | -4.0% | 0.00% | -66.7% |
| Q4 2020 | $2,019,000 | +52.0% | 43,713 | +15.8% | 0.00% | +50.0% |
| Q3 2020 | $1,328,000 | +138.0% | 37,750 | +64.8% | 0.00% | +100.0% |
| Q2 2020 | $558,000 | – | 22,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |